491 results on '"Matsumoto, Shigemi"'
Search Results
102. Clinical significance of TP53 variants as possible secondary findings in tumor-only next-generation sequencing
103. Association between preanalytical factors and tumor mutational burden estimated by NGS-based multiplex gene panel assay
104. The effect of proton pump inhibitors on the efficacy of nivolumab monotherapy in different types of cancer
105. Association Between Preanalytical Factors and Tumor Mutational Burden Estimated by Next-Generation Sequencing-Based Multiplex Gene Panel Assay
106. Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab
107. Association between sample characteristics and tumor mutational burden estimated by next-generation sequencing-based multiplex gene panel assay.
108. Utility of ultrasound‐guided liver tumor biopsy for next‐generation sequencing‐based clinical sequencing
109. Clinical Practice of Postoperative Adjuvant Chemotherapy in Patients with Colorectal Liver Metastases: Impact of the Completion for Six Months
110. Response to imatinib in vaginal melanoma withKITp.Val559Gly mutation previously treated with nivolumab, pembrolizumab and ipilimumab
111. Comprehensive genomic profiling for patients with chemotherapy‐naïve advanced cancer.
112. Clinical impact of baseline renal function on safety and early discontinuation of adjuvant capecitabine plus oxaliplatin in elderly patients with resected colon cancer: a multicenter post-marketing surveillance study.
113. Predicting marker for early progression in unresectable melanoma treated with nivolumab
114. Clinical results of dynamic tumor tracking intensity-modulated radiotherapy with real-time monitoring for pancreatic cancers using a gimbal mounted linac
115. Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer
116. A Prospective, Randomized Comparison of the Postoperative Administration of Tramadol and Morphine following Primary Total Knee Arthroplasty
117. In response
118. Clinical sequencing using a next-generation sequencing-based multiplex gene assay in patients with advanced solid tumors
119. Therapeutic Potential of Afatinib for Cancers with ERBB2 (HER2) Transmembrane Domain Mutations G660D and V659E
120. Development and validation of a set of six adaptable prognosis prediction (SAP) models based on time-series real-world big data analysis for patients with cancer receiving chemotherapy: A multicenter case crossover study
121. Clinical impact of renal impairment on safety in elderly colon cancer patients receiving capecitabine plus oxaliplatin as adjuvant therapy; multicenter post-marketing surveillance study
122. Clinical sequencing using a next-generation sequencing-based multiplex gene assay in patients with advanced solid tumors
123. Impact of BRCAness on the efficacy of oxaliplatin-based chemotherapy in patients with unresectable pancreatic cancer.
124. S-1 Salvage Chemotherapy for Esophageal Squamous Cell Carcinoma Refractory to the Standard Chemotherapy
125. Precision medicine based on a multiplex gene panel （OncoPrime™）
126. Clinical significance of TP53variants as possible secondary findings in tumor-only next-generation sequencing
127. Paraneoplastic limbic encephalitis in a human epidermal growth factor receptor-2-positive gastric cancer patient treated with trastuzumab-combined chemotherapy: A case report and literature review
128. MO3-10-1 - The effect of proton pump inhibitors on the efficacy of nivolumab monotherapy in different types of cancer
129. MO2-1-4 [Encore] - Association between preanalytical factors and tumor mutational burden estimated by NGS-based multiplex gene panel assay
130. Association between UGT1A1*28*28 genotype and lung cancer in the Japanese population
131. Implementation of clinical sequencing using a comprehensive gene panel (OncoPrimeTM)
132. Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers
133. Successful conservative management of diffuse cavernous hemangioma of the rectum
134. Dermoscopic changes in malignant melanoma after successful treatment with nivolumab: A case report
135. Abstract 4496: Genomic profiling of late stage tumors powering precision medicine in Japan
136. The possibility of clinical sequencing in the management of cancer
137. Paraneoplastic Limbic Encephalitis in a Human Epidermal Growth Factor Receptor-2-positive Gastric Cancer Patient Treated with Trastuzumab-combined Chemotherapy: A Case Report and Literature Review
138. Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
139. Therapeutic Potential of Afatinib for Cancers with <italic>ERBB2</italic> (<italic>HER2</italic>) Transmembrane Domain Mutations G660D and V659E.
140. Introduction of clinical sequence using a comprehensive cancer gene panel (OncoPrime) to daily clinical practice
141. Establishment of a terminal prognosis prediction model by applying time series analysis to real-world data
142. A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute
143. Feasibility of the liver-first approach for patients with initially unresectable and not optimally resectable synchronous colorectal liver metastases
144. Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy
145. Prognostic model for survival in patients with advanced pancreatic cancer receiving palliative chemotherapy.
146. アウトカム ケンキュウ ノ タメ ノ デンシ カルテ ト レンドウシタ データベース システム ノ コウチク : ソノ セイカ ト カノウセイ ニ ツイテ
147. PD-021 - Clinical impact of renal impairment on safety in elderly colon cancer patients receiving capecitabine plus oxaliplatin as adjuvant therapy; multicenter post-marketing surveillance study
148. DISPLACEMENT BEHAVIOR AROUND TUNNEL INTERSECTION IN WEAK ROCK
149. Overcoming the Challenges of Primary Tumor Management in Patients With Metastatic Colorectal Cancer Unresectable for Cure and an Asymptomatic Primary Tumor
150. Efficacy and safety of anti-PD-1 antibody (Nivolumab: BMS-936558, ONO-4538) in patients with platinum-resistant ovarian cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.